# Peter Zardo Managing Director ## Career chronology - **More than 17 years before April 2020: Westpac Group** — Senior leadership, corporate and institutional banking; earlier financial/equity markets. [Our People]() (Our People, Peter Zardo biography, lines 59–63) - **7 April 2020 to July 2020: Zeotech Limited** — Chief Operating Officer. [Annual Report 2025]() (pp. 21–22, Peter Zardo service agreement; role commenced COO and amended to MD July 2020) - **July 2020 to cutoff: Zeotech Limited** — Managing Director. [Annual Report 2025]() (pp. 21–22, Peter Zardo service agreement) ## Education and qualifications ### Education and professional qualification [zeo_peter_zardo_education] As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality The issuer states that Zardo undertook Applied Science studies at Charles Sturt University and is an MAICD member. It does not identify a degree or graduation date; these claims are not independently verified. **Attribution:** Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained. **Relevance:** Relevant to role-fit assessment and subject to verification gap. [Our People]() (Our People, Peter Zardo biography, lines 61–63) ## Contributions and company outcomes ### FY2026 project and commercial milestones [zeo_peter_zardo_fy26_delivery] FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate managing director's personal contribution or establish booked DSO/AusPozz sales. **Attribution:** Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented. **Relevance:** Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue. [Annual Report to shareholders]() (FY2026 annual report, Chair/MD reports and operating review); [Quarterly Activities and Appendix 5B Cash Flow Report]() (pp. 1–8, activities report) ## Business failures and setbacks ### Pre-commercial status and funding dependence [zeo_peter_zardo_fy26_funding] FY2026 to 2026-06-30 · issuer reported · medium materiality FY2026 reporting showed the Group remained pre-commercial, with a larger annual loss and operating cash outflow than the prior year; the annual report disclosed that additional funding may be needed to continue operations and develop assets. This is a company-level execution/funding risk during the executive's tenure, not evidence of personal misconduct or sole responsibility. **Attribution:** Role overlaps event; causation unproven. The MD role overlapped the reported period; no personal causal attribution is established. **Relevance:** Material to assessing delivery and capital allocation for a development-stage company. [Annual Report to shareholders]() (FY2026 annual report, financial statements and going-concern funding risk) ## Litigation and enforcement ### Unresolved exact-name court match: Fair Work Act penalty [zeo_peter_zardo_name_match_2017] 2015 incident; judgment 2017-04-07 · documented · medium materiality A 2017 Federal Circuit Court judgment names a Peter Zardo as the third respondent and found a contravention of Fair Work Act s.502(1): the court found deliberate and persistent obstruction of a permit holder seeking to consult a worker, and imposed a $1,000 penalty. The published judgment identifies project-management activity at a construction site but does not identify Zeotech, Westpac, or the executive biography; identity match to Zeotech’s MD is therefore unconfirmed and the finding is not attributed to him. The retrieved judgment contains no later appeal or correction reference; no appellate search located a later resolution. **Attribution:** Responsibility unresolved. The court made a finding against the exact-name respondent, but source material does not establish that he is the Zeotech executive. **Relevance:** Potentially relevant only if identity can be established; no executive misconduct conclusion is drawn from name alone. [Construction, Forestry, Mining and Energy Union v Class 1 Form Pty Ltd \[2017\] FCCA 696]() (paras. 44–48, 55–73, 103–111 and 331–343) ### Abercorn project milestone-rights litigation settled [zeo_peter_zardo_abercorn_settlement] 2023; acquisition term sheet dated 2019-08-09 · issuer reported · medium materiality Zeotech reported that court-ordered mediation over milestone performance rights issued as consideration for the 2019 Abercorn acquisition concluded in 2023, with a binding settlement/release and discontinuance of both proceedings conditional on shareholder approval. The disclosure does not describe any finding of wrongdoing by the named executive; the dispute originated in a pre-appointment transaction and settlement terms were company-level. **Attribution:** Role overlaps event; causation unproven. The MD/CEO roles overlapped settlement execution/oversight; no personal involvement or wrongdoing is documented. **Relevance:** Relevant as company legal/governance context; resolution status disclosed as settlement, not adjudication of merits. [Quarterly Activities Report (March 2023 quarter)]() (p. 8, Settlement of legal proceedings) ## Suitability for the current role ### Role relevance and evidenced background [zeo_peter_zardo_fit] Background reviewed through 2026-10-09 · analyst inference · low materiality The issuer reports 17+ years with Westpac, joining Zeotech as COO in 2020 and becoming MD in July 2020; it describes finance and commercialisation experience. Current title in the selected roster: Managing Director. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes. **Attribution:** Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made. **Relevance:** Relevant to the current Managing Director responsibilities, subject to the evidence limitations recorded below. [Our People]() (Executive biography or corporate-directory entry for the named person) ## Evidence gaps - The exact-name 2017 court respondent cannot be confirmed as the Zeotech executive from the judgment; no independent identifier or employer link was found. - Applied Science study is not reported as a completed degree; Westpac chronology and concurrent interests have not been independently verified. - No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.